Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Impaired Nodal Shrinkage and Apoptosis Lacking Define the Adverse Independent Clinical Outcome of NOTCH1 mutated Chronic Lymphocytic Leukemia (CLL) Patients in the Age of Targeted Agents (TA)

Giovanni Del Poeta, MD, Annalisa Biagi, MD, Annalisa Chiarenza, MD PhD, Luca Laurenti, MD, Federico Pozzo, MSc, Idanna Innocenti, MD PhD, Riccardo Bomben, PhD, Maria Ilaria Del Principe, Enrico Santinelli, MD, Francesca Maria Rossi, PhD, Paolo de Fabritiis, MD, Maria Cantonetti, Antonella Zucchetto, William Arcese, Valter Gattei, MD

Blood (2019) 134 (Supplement_1): 1744.

https://doi.org/10.1182/blood-2019-122481

Published: 2019

Journal Articles

Impact of Serum Immunoglobulin Subsets and Levels on Chronic Lymphocytic Leukemia Natural History: A Retrospective Multicentric Italian Experience

Luca Laurenti, MD, Andrea Corbingi, MD, Idanna Innocenti, MD PhD, Annamaria Tomasso, Raffaella Pasquale, MD, Andrea Visentin, MD, Marzia Varettoni, Francesco Autore, MD, Francesca Morelli, Livio Trentin, MD, Gianluigi Reda, MD

Blood (2019) 134 (Supplement_1): 3026.

https://doi.org/10.1182/blood-2019-128351

Published: 2019

Journal Articles

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)

Patrizia Chiusolo, Andrea Bacigalupo, MD, Simona Sica, MD, Sabrina Giammarco, MD PhD, Elisabetta Metafuni, Federica Sora, MD, Luca Laurenti, MD, Francesco Autore, MD, Idanna Innocenti, MD PhD, Silvia Bellesi, Gina Zini, MD PhD, Maria Bianchi, Caterina Giovanna Valentini, Luciana Teofili, MD

Blood (2019) 134 (Supplement_1): 3332.

https://doi.org/10.1182/blood-2019-130849

Published: 2019

Journal Articles

A CRISPR/Cas9-Generated Murine Model Reveals Cooperation between BCR Signaling and CDKN2A/2B and TP53 Disruption in Richter Syndrome

Supriya Chakraborty, PhD, Ilaria Fortunati, BS, Claudio Martines, MS, Brijesh Yadav, PhD, Marija Dimishkovska, PhD, Idanna Innocenti, MD PhD, Rosa Fazio, BS, Giovanni D'Arena, MD, Aleksandar Dimovski, MD PhD, Luca Laurenti, MD, Dimitar G Efremov, MD PhD

Blood (2019) 134 (Supplement_1): 4278.

https://doi.org/10.1182/blood-2019-128425

Published: 2019

Journal Articles

Clinical Relevance of NOTCH1 Mutations in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

Blood (2018) 132 (Supplement 1): 4396.

https://doi.org/10.1182/blood-2018-99-113074

Published: 2018

Journal Articles

A Laboratory Based Scoring System Predicts Early Treatment in Rai 0/Binet a CLL

Blood (2018) 132 (Supplement 1): 4399.

https://doi.org/10.1182/blood-2018-99-112162

Published: 2018

Journal Articles

Serum IgM/Fcmr Interactions Inhibit BCR Signaling and Influence the Cinical Course of CLL

Stefania Gobessi, PhD, Luca Laurenti, MD, Fabiola Porro, MS, Claudio Martines, MS, Rosa Fazio, BS, Elena Xerxa, PhD, Idanna Innocenti, MD PhD, Antonella Zucchetto, Shih-Shih Chen, PhD, Xiao-Jie Yan, MD PhD, Nicholas Chiorazzi, MD, Valter Gattei, MD, Dimitar G Efremov, MD PhD

Blood (2018) 132 (Supplement 1): 4409.

https://doi.org/10.1182/blood-2018-99-118562

Published: 2018

Journal Articles

EARLY Post-Transplant Events , Cost of Admission and Mortality, in Patients Undergoing Allogeneic Transplants from Identical Siblings, Unrelated Donors or Haploidentical Donors

Federica SORA, MD, Patrizia Chiusolo, MD, Luca Laurenti, MD, Sabrina Giammarco, MD PhD, Francesco Autore, MD, Idanna Innocenti, MD PhD, Simona Sica, MD, Metafuni Elisabetta, Andrea Bacigalupo, MD

Blood (2018) 132 (Supplement 1): 4648.

https://doi.org/10.1182/blood-2018-99-116506

Published: 2018

Journal Articles

Monoclonal Gammopathy and Hypogammaglobulinemia As Prognostic Factors in Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicentric Experience

Idanna Innocenti, MD PhD, Andrea Corbingi, MD, Nicola Piccirillo, MD, Francesco Autore, MD, Andrea Visentin, MD, Edoardo Scomazzon, MD, Ramona Cassin, MD, Raffaella Pasquale, MD, Francesca Morelli, Simona Sica, MD, Gianluigi Reda, MD, Livio Trentin, MD, Luca Laurenti, MD

Blood (2018) 132 (Supplement 1): 5542.

https://doi.org/10.1182/blood-2018-99-119371

Published: 2018

Journal Articles

Real Life Use of Bendamustine Plus Rituximab Versus Chlorambucil Plus Rituximab As Front-Line Therapy for Elderly CLL Patients. Retrospective Multicenter Study in the Lazio Region

Francesco Autore, MD, Idanna Innocenti, MD PhD, Francesco Corrente, Maria Ilaria Del Principe, MD, Serena Rosati, MD, Paolo Falcucci, Esmeralda Conte, Maria Assunta Limongiello, Daniela Renzi, Laura De Padua, MD, Alessandro Andriani, MD, Francesco Pisani, MD, Giuseppe Cimino, Agostino Tafuri, MD, Marco Montanaro, MD, Francesca Romana Mauro, Giovanni Del Poeta, MD, Luca Laurenti, MD

Blood (2018) 132 (Supplement 1): 5550.

https://doi.org/10.1182/blood-2018-99-119408

Published: 2018

Journal Articles

Risk of Infectious Complications in Patients with Chronic Lymphocytic Leukemia in the Era of BCR Inhibitors: A Retrospective Single Institution Experience

Francesco Autore, MD, Idanna Innocenti, MD PhD, Francesca Morelli, Federica Sora, Andrea Corbingi, MD, Denise Soldati, Luana Fianchi, MD, Marianna Criscuolo, Livio Pagano, Andrea Bacigalupo, MD, Simona Sica, MD, Luca Laurenti, MD

Blood (2018) 132 (Supplement 1): 5552.

https://doi.org/10.1182/blood-2018-99-119654

Published: 2018

Journal Articles

Which Is the Best Mobilizing Regimen in POEMS Syndrome? a Retrospective Italian Study of Two Haematological Centres

Francesco Autore, MD, Nicola Piccirillo, MD, Andrea Nozza, MD, Idanna Innocenti, MD PhD, Rossana Putzulu, MD, Patrizia Chiusolo, MD, Federica Sora, MD, Gina Zini, MD PhD, Andrea Bacigalupo, MD, Luca Castagna, MD, Simona Sica, MD, Stefania Bramanti, MD, Luca Laurenti, MD

Blood (2018) 132 (Supplement 1): 5692.

https://doi.org/10.1182/blood-2018-99-118554

Published: 2018

Journal Articles

Characterization and Prognostic Relevance of Circulating Microvesicles in Chronic Lymphocytic Leukemia

Luciana De Luca, Giovanni D'Arena, MD, Vittorio Simeon, PhD, Stefania Trino, PhD, Ilaria Laurenzana, PhD, Antonella Caivano, Francesco La Rocca, Oreste Villani, MD, Giovanna Mansueto, MD, Silvia Deaglio, MD PhD, Idanna Innocenti, MD, Luca Laurenti, Stefano Molica, MD, Giuseppe Pietrantuono, MD, Angelo De Stradis, Luigi Del Vecchio, MD, Pellegrino Musto, MD

Blood (2016) 128 (22): 4375.

https://doi.org/10.1182/blood.V128.22.4375.4375

Published: 2016

Journal Articles

The Bcl-2 BH4 Antagonist Bda-366 Induces Apoptosis in CLL and DLBCL Cells through a Bcl-2 Independent Mechanism

Binu K Sasi, PhD, Tamara Vervloessem, PhD, Stefania Gobessi, PhD, Idanna Innocenti, MD, Luca Laurenti, Geert Bultynck, PhD, Dimitar G Efremov, MD PhD

Blood (2016) 128 (22): 2014.

https://doi.org/10.1182/blood.V128.22.2014.2014

Published: 2016

Journal Articles

FcμR Triggering Activates BCR Signaling Pathways and Increases Survival of CLL Cells

Stefania Gobessi, PhD, Binu K Sasi, PhD, Gabriele Pozzato, MD, Idanna Innocenti, MD, Luca Laurenti, Dimitar G Efremov, MD PhD

Blood (2016) 128 (22): 2015.

https://doi.org/10.1182/blood.V128.22.2015.2015

Published: 2016

Journal Articles

Impact of BCR Stimulation on Mir-181b in Chronic Lymphocityc Leukemia

Amerigo Mirco Di Marco, Francesco Autore, MD, Paola Lanuti, Idanna Innocenti, MD, Giuseppe Leone, MD, Alice Ramassone, Angelo Veronese, Renato Mariani Costantini, Luca Laurenti, Rosa Visone

Blood (2016) 128 (22): 2026.

https://doi.org/10.1182/blood.V128.22.2026.2026

Published: 2016

Journal Articles

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/ TP 53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Blood (2016) 128 (22): 2038.

https://doi.org/10.1182/blood.V128.22.2038.2038

Published: 2016

Journal Articles

Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification

Blood (2016) 128 (22): 3240.

https://doi.org/10.1182/blood.V128.22.3240.3240

Published: 2016

Journal Articles

LDH Levels Predict Progression-Free Survival in Treatment-NaÏVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia

Francesco Autore, MD, Paolo Strati, MD, Idanna Innocenti, MD, Francesco Corrente, Livio Trentin, MD, Agostino Cortelezzi, MD, Marta Coscia, MD PhD, Alessandro Gozzetti, MD, Massimo Gentile, MD, Fortunato Morabito, MD, Giovanni D'Arena, MD, Roberta Murru, MD, Donatella Iolanda Vincelli, MD, Gianluigi Reda, MD, Candida Vitale, MD, Alessandra Ferrajoli, MD, Luca Laurenti

Blood (2016) 128 (22): 3211.

https://doi.org/10.1182/blood.V128.22.3211.3211

Published: 2016

Journal Articles

Inhibition of SYK More Effectively Overcomes MCL-1 Mediated ABT-199 Resistance of BCR-Stimulated CLL Cells Than Inhibition of BTK or PI3Kdelta

Kamil Bojarczuk, PhD, Binu K Sasi, PhD, Stefania Gobessi, PhD, Idanna Innocenti, MD, Luca Laurenti, MD, Dimitar G Efremov, MD PhD

Blood (2015) 126 (23): 489.

https://doi.org/10.1182/blood.V126.23.489.489

Published: 2015

NARROW

Impaired Nodal Shrinkage and Apoptosis Lacking Define the Adverse Independent Clinical Outcome of NOTCH1 mutated Chronic Lymphocytic Leukemia (CLL) Patients in the Age of Targeted Agents (TA)

Impact of Serum Immunoglobulin Subsets and Levels on Chronic Lymphocytic Leukemia Natural History: A Retrospective Multicentric Italian Experience

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)

A CRISPR/Cas9-Generated Murine Model Reveals Cooperation between BCR Signaling and CDKN2A/2B and TP53 Disruption in Richter Syndrome

Clinical Relevance of NOTCH1 Mutations in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

A Laboratory Based Scoring System Predicts Early Treatment in Rai 0/Binet a CLL

Serum IgM/Fcmr Interactions Inhibit BCR Signaling and Influence the Cinical Course of CLL

EARLY Post-Transplant Events , Cost of Admission and Mortality, in Patients Undergoing Allogeneic Transplants from Identical Siblings, Unrelated Donors or Haploidentical Donors

Monoclonal Gammopathy and Hypogammaglobulinemia As Prognostic Factors in Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicentric Experience

Real Life Use of Bendamustine Plus Rituximab Versus Chlorambucil Plus Rituximab As Front-Line Therapy for Elderly CLL Patients. Retrospective Multicenter Study in the Lazio Region

Risk of Infectious Complications in Patients with Chronic Lymphocytic Leukemia in the Era of BCR Inhibitors: A Retrospective Single Institution Experience

Which Is the Best Mobilizing Regimen in POEMS Syndrome? a Retrospective Italian Study of Two Haematological Centres

Characterization and Prognostic Relevance of Circulating Microvesicles in Chronic Lymphocytic Leukemia

The Bcl-2 BH4 Antagonist Bda-366 Induces Apoptosis in CLL and DLBCL Cells through a Bcl-2 Independent Mechanism

FcμR Triggering Activates BCR Signaling Pathways and Increases Survival of CLL Cells

Impact of BCR Stimulation on Mir-181b in Chronic Lymphocityc Leukemia

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/ TP 53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification

LDH Levels Predict Progression-Free Survival in Treatment-NaÏVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia

Inhibition of SYK More Effectively Overcomes MCL-1 Mediated ABT-199 Resistance of BCR-Stimulated CLL Cells Than Inhibition of BTK or PI3Kdelta

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only